HHLR Advisors’s Gossamer Bio GOSS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.63M Hold
4,974,041
0.1% 23
2025
Q4
$15.4M Hold
4,974,041
0.5% 14
2025
Q3
$13.1M Hold
4,974,041
0.32% 17
2025
Q2
$6.12M Hold
4,974,041
0.2% 21
2025
Q1
$5.47M Hold
4,974,041
0.15% 25
2024
Q4
$4.5M Hold
4,974,041
0.16% 24
2024
Q3
$4.91M Hold
4,974,041
0.11% 24
2024
Q2
$4.48M Hold
4,974,041
0.11% 40
2024
Q1
$5.87M Hold
4,974,041
0.13% 36
2023
Q4
$4.54M Hold
4,974,041
0.09% 34
2023
Q3
$4.14M Hold
4,974,041
0.09% 44
2023
Q2
$5.97M Hold
4,974,041
0.13% 42
2023
Q1
$6.27M Hold
4,974,041
0.11% 49
2022
Q4
$10.8M Sell
4,974,041
-2,446,933
-33% -$20.1M 0.23% 39
2022
Q3
$88.9M Hold
7,420,974
2.34% 13
2022
Q2
$62.1M Hold
7,420,974
1.33% 19
2022
Q1
$64.4M Hold
7,420,974
1.34% 15
2021
Q4
$83.9M Hold
7,420,974
1.3% 17
2021
Q3
$93.3M Hold
7,420,974
1.22% 18
2021
Q2
$60.3M Hold
7,420,974
0.62% 26
2021
Q1
$68.6M Hold
7,420,974
0.68% 25
2020
Q4
$71.8M Hold
7,420,974
0.57% 27
2020
Q3
$92.1M Hold
7,420,974
0.7% 25
2020
Q2
$96.5M Buy
7,420,974
+1,509,433
+26% +$19M 0.88% 24
2020
Q1
$60M Hold
5,911,541
0.81% 23
2019
Q4
$92.4M Hold
5,911,541
1.15% 20
2019
Q3
$99.3M Buy
5,911,541
+4,974,041
+531% +$98.9M 1.36% 19
2019
Q2
$20.8M Hold
937,500
0.47% 29
2019
Q1
$20.3M Buy
+937,500
New +$19.6M 0.57% 22

Other funds holding GOSS

HHLR Advisors's GOSS Position: Q1 2026 in Review

HHLR Advisors held its Gossamer Bio (GOSS) position steady in Q1 2026 at 4,974,041 shares worth $1.63M. The position accounts for 0.1% of the portfolio, ranked #23.

HHLR Advisors first reported a position in GOSS in Q1 2019 and has held it in 29 quarters since. The position peaked at $99.3M in Q3 2019. 184 funds tracked by Wall St. Rank hold GOSS as of Q1 2026.

  • HHLR Advisors held 4,974,041 shares of Gossamer Bio worth $1.63M as of Q1 2026.
  • HHLR Advisors left its Gossamer Bio share count unchanged in Q1 2026.
  • Gossamer Bio made up 0.1% of HHLR Advisors's portfolio in Q1 2026, its #23 holding.
  • HHLR Advisors first reported a position in Gossamer Bio in Q1 2019 and has held it in 29 quarters since.
  • HHLR Advisors's Gossamer Bio position peaked at $99.3M in Q3 2019.
  • 184 funds tracked by Wall St. Rank held Gossamer Bio as of Q1 2026.

Based on HHLR Advisors's 13F filing for Q1 2026, filed 15 May 2026.